CN Patent

CN101531653B — 3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基)哌啶-2,6-二酮及其衍生物的盐或盐的多晶型物及其制备和应用

Assigned to Xiajiang Hemei Pharmaceutical Co ltd · Expires 2014-07-09 · 12y expired

What this patent protects

3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮及其衍生物的盐或盐的多晶型物及其制备和应用本发明公开了3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮的药学上可接受的强酸盐及其溶剂化物，它们的制备和用于制备可治疗由抑制炎症因子或新生血管生成即可达成疗效的那些疾病或生理异常的药物的应用。本发明所提供的3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮的药学上可接受的强酸盐，其水溶性远远大于3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮自由碱的水溶性，本发明还公开…

USPTO Abstract

3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮及其衍生物的盐或盐的多晶型物及其制备和应用本发明公开了3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮的药学上可接受的强酸盐及其溶剂化物，它们的制备和用于制备可治疗由抑制炎症因子或新生血管生成即可达成疗效的那些疾病或生理异常的药物的应用。本发明所提供的3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮的药学上可接受的强酸盐，其水溶性远远大于3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮自由碱的水溶性，本发明还公开了3-(4-氨基-1-氧代-1，3-二氢异吲哚-2-基)哌啶-2，6-二酮的药学上可接受的强酸盐及其溶剂化物的多晶型物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101531653B
Jurisdiction
CN
Classification
—
Expires
2014-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Xiajiang Hemei Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.